Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?

In this cohort, racial disparities may be due to higher medical comorbidities and lower rates of optimal surgical cytoreduction. After accounting for these differences, race remained an independent predictor of worse overall survival.